Early Diagnosis of and R&D in Lysosomal Storage Disorders to Augment Growth of Lysosomal Alpha Glucosidase Market
Acid alpha-glucosidase is an enzyme that helps to break down glycogen in the lysosome. Lysosomal acid alpha-glucosidase deficiency may lead to Pompe disease, glycogen storage disease II, and acid maltase deficiency. Market Dynamics Early diagnosis of lysosomal storage disorders is expected to propel growth of the lysosomal alpha glucosidase market. For instance, in January 2021, in the U.S., The Kansas Department of Health and Environment, added two lysosomal storage disorders to the Kansas Newborn Screening blood spot panel: Pompe Disease and Mucopolysaccharidoses I (MPS I). R&D in lysosomal storage disorders is expected to offer lucrative growth opportunities for players in the lysosomal alpha glucosidase market . For instance, in October 2020, The European Medicines Agency accepted for review the Marketing Authorization Application for avalglucosidase alfa, for long-term enzyme replacement therapy for the treatment of patients with Pompe disease (acid a-glucosidase d...